Sanofi has asked the U.S. Food and Drug Administration to pull its diabetes drug out of the regulator's new fast-track review ...
Food and Drug Administration has approved Partner Therapeutics' drug for adults with a rare form of bile duct cancer as ...
Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the ...
The Trump administration recently released its National Drug Control Strategy (the Strategy). The Strategy highlights, ...
Newsmax on MSN
Trump puts drug pricing program fraudsters on notice
Trump Puts Drug Pricing Program Fraudsters on Notice ...
On April 23, President Trump unveiled a drug pricing deal with Regeneron, which became the 17th company to strike a deal as part of what is known as the ...
2don MSNOpinion
President Trump’s drug control strategy sets the path to end the drug crisis for good
Trump's 2026 National Drug Control Strategy targets cartel supply chains, expands addiction treatment, and introduces a new ...
The two companies with the steepest increases market blockbuster medications that saw deep price cuts in 2026.
Savings from MFN Drug Pricing PolicyDownload Executive Summary The Trump Administration has designed a Most-Favored-Nation (MFN) drug pricing policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results